Spark Investment Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Spark Investment Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,072	Closed	-$44K	–	323
2020 Q1	$44K	Sell	18,072 -31,374	-63%	-$113K	0.02%	318
2019 Q4	$253K	Sell	49,446 -8,154	-14%	-$45.2K	0.03%	421
2019 Q3	$372K	Buy	57,600 +20,600	+56%	+$142K	0.05%	275
2019 Q2	$230K	Buy	+37,000	New	+$282K	0.02%	448
2019 Q1	–	Sell	-11,919	Closed	-$94K	–	747
2018 Q4	$94K	Buy	+11,919	New	+$172K	0.01%	568
2017 Q1	–	Sell	-5,550	Closed	-$551K	–	918
2016 Q4	$551K	Buy	+5,550	New	+$584K	0.05%	470

Other funds holding SIOX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spark Investment Management's SIOX Position: Q2 2020 in Review

Spark Investment Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2020, closing a stake of 18,072 shares — an estimated $44K sold.

Spark Investment Management first reported a position in SIOX in Q4 2016 and held it in 6 quarters. The position peaked at $551K in Q4 2016. 40 funds tracked by Wall St. Rank hold SIOX as of Q2 2020.

Spark Investment Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 18,072 Sio Gene Therapies Inc. Common Stock shares in Q2 2020, an estimated $44K.
Spark Investment Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Spark Investment Management's Sio Gene Therapies Inc. Common Stock position peaked at $551K in Q4 2016.
40 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.